Quanterix Corp
NASDAQ:QTRX
| Market Cap (Intraday) | 1.93B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $48.56 |
| 50-Day MA | $51.16 |
| 200-Day MA | $57.95 |
Quanterix Corp Stock, NASDAQ:QTRX
Building 1, 900 Middlesex Turnpike, Billerica, Massachusetts 01821
United States of America
Phone: +1.617.301.9400
Number of Employees: 314
Description
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.